Atomo Diagnostics is a global leader in the design of medical devices for blood-based rapid testing for professional use and self-testing.

Atomo’s innovative rapid diagnostic test (RDT) platforms simplify procedures, mitigate common user errors, and enhance test performance.  Their unmatched usability has won the respect of frontline healthcare providers worldwide, and has made Atomo the OEM partner of choice for diagnostic companies wanting to enhance their RDT product offerings.

Device Portfolio >

Self-Test Platform >

OEM Service >

Unmatched Usability

User-centred design for professional use & self-test applications.

Proven Performance

Award-winning device platforms that are proven to mitigate user errors. 

Efficient Development

Validated processes to accelerate custom device development.

Integrated RDT platforms

Award-winning AtomoRapid™ RDT platforms remove the need for multiple test components by integrating features into a single device. With assorted functionality, Atomo platforms greatly simplify test procedures.

Browse our Portfolio >

Self-testing made simpler

With a built-in safety lancet, unique blood collection feature, single action blood and buffer delivery system, and interlocked user steps, the AtomoRapid™ Elion self-test platform provides unprecedented usability and performance.

Evaluate self-test features >

Custom device development

Devices are customisable to suit your requirements and modified to match the specifics of your test strip. From manufacturing process validation to post launch marketing, benefit from Atomo’s dedicated support every step of the way.

Partner with Atomo >

BIVDA2018-200x180

Atomo HIV Self Test

The Atomo HIV Self Test is now available in Australia directly from Atomo Diagnostics, and is the first and only HIV self-test to have been approved by the Australian Therapeutic Goods Administration (TGA).

Find out more >

Partner with Atomo for an efficient, low-risk pathway from product development to commercialisation of your best-in-class rapid diagnostic test.

 

Get in touch >

Atomo News

Atomo DiagnosticsFollow

Atomo Diagnostics
Retweet on TwitterAtomo Diagnostics Retweeted
FWResearchFutureWise Market Research@FWResearch·
15 Jul

After being the only #HIVSelfTest approved by @TGAgovau in Australia, the #HIVSelfTest by @MylanNews & @AtomoDiagnostic gets #WHO Prequalification approval. The #PreFilledAutoInjectorsMarket is soaring & has untapped potential, to acquire further insights; https://t.co/wjlPhRaMn4

Reply on Twitter 1150754471653384197Retweet on Twitter 11507544716533841971Like on Twitter 11507544716533841971Twitter 1150754471653384197
Retweet on TwitterAtomo Diagnostics Retweeted
Pharmacy_TimesPharmacy Times@Pharmacy_Times·
10 Jul

A handheld in-vitro #HIV rapid diagnostic test for self-testing, developed by Mylan N.V. and @AtomoDiagnostic has been given Prequalification approval by the World Health Organization.
@WHO
More: https://t.co/Hxfw4Lk9cI

Reply on Twitter 1149015432696745984Retweet on Twitter 11490154326967459844Like on Twitter 11490154326967459846Twitter 1149015432696745984
Retweet on TwitterAtomo Diagnostics Retweeted
LabPulse1LabPulse@LabPulse1·
9 Jul

Mylan/Atomo's finger stick #HIV test is being aimed at more than 100 low- and middle-income countries. @AtomoDiagnostic @MylanNews https://t.co/HvAL97QXAb

Reply on Twitter 1148635641858658306Retweet on Twitter 11486356418586583061Like on Twitter 1148635641858658306Twitter 1148635641858658306
Load More...